Why Acuvi stock moves
Acuvi fell sharply, more than the market.
Written after the close on ·
Why today
16,415 news analyzed todayAcuvi fell sharply, more than the market.
The market was down clearly that session, so part of the drop was broad selling.
The stock fell clearly over the last five trading days while the market was roughly flat.
Trading was about three times its usual level, a sign of heavy activity.
Today's move of −3.48% was 3.2 times a normal day's 1.1%. OMX Stockholm 30 moved −1.01% on the same day.
Acuvi −3.48%OMX Stockholm 30 −1.01%Much weaker than the market
Has the share price followed the business?
Price and earnings moved in the same direction: 1 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +7% and earnings per share went from 1.04 SEK to -0.47 SEK.
Revenue, profit and market cap
RevenueProfitMarket capm SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capm SEK
Price and earnings moved in the same direction: 1 out of 3 years.Market cap (Now): 194 m SEKRevenue 2025: 204 m SEK
What the key figures say about Acuvi
The figures connect what Acuvi earns with what investors pay.
The line shows the share price in the same year, on its own scale.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -3.86 SEK–1.04 SEK. Peers: Aspocomp Group 0.14 EUR, poLight -0.54 NOK, NOTE 8.81 SEK.
What the company sold during the year.
2022–2025: 176 m SEK–204 m SEK. Peers: Aspocomp Group 39.8 m EUR, poLight 34.1 m NOK, NOTE 4.2 bn SEK.
The percentage of revenue left after the costs of running the business.
2022–2025: −62.6%–10.2%. Peers: Aspocomp Group 3.9%, poLight −367.2%, NOTE 9.0%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −28.2%–6.6%. Peers: Aspocomp Group 5.9%, poLight −36.2%, NOTE 14.3%.
What investors pay for each unit the company sells.
2022–2025: 1.15–2.82. Peers: Aspocomp Group 1.16, poLight 76.44, NOTE 1.04.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 0.00 SEK–3.58 SEK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 0.0%–0.0%. Peers: Aspocomp Group 0.0%, poLight 0.0%, NOTE 0.0%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 1.04–2.11. Peers: Aspocomp Group 2.35, NOTE 3.13.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 0.62–1.44. Peers: Aspocomp Group 2.28, poLight 9.65, NOTE 2.24.
Cash left after investments, divided by the number of shares.
2022–2025: -0.93 SEK–0.48 SEK. Peers: Aspocomp Group 0.02 EUR, poLight -0.38 NOK, NOTE 5.29 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 65.0%–81.1%.
What followed similar falls?
Including reinvested dividends, Acuvi fell 7.3% over the latest five trading days. Since November 7, 2016, falls at least this large were followed by a higher value 21 trading days later in 32 out of 63 non-overlapping periods. The median was +2.0%, against −2.4% for an ordinary 21-day period, which ended higher 42 times in 100.
Such a fall has not said much about the next month.
+2.0% · 32/63
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. April 30: Buy about 206 thousand SEK. February 26: Buy about 186 thousand SEK.
More about Acuvi
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Nils Sjöholm, CEOBuyabout 206 thousand SEK
- Nils Sjöholm, CEOBuyabout 186 thousand SEK
Earnings report
On its last 15 report days Acuvi usually moved about 5.7%. On a normal day it moves 1.1%.
+1.04% −13.94% −4.00% −2.37%
10,000 SEK in Acuvi bought on November 7, 2016 is worth 7,120 SEK today, with dividends reinvested.
What would 10,000 SEK in Acuvi be worth today? →
What would 10,000 SEK in Acuvi be worth today?
7,120 SEK
with dividends reinvested, bought on November 7, 2016.
At worst it was worth 7,120 SEK (November 6, 2026).
The five biggest days of the journey
· +51.9% · the whole market fell 0.5% the same day
· +43.8% · the whole market rose 0.5% the same day
· +37.2% · the whole market rose 0.5% the same day
· +36.1% · the whole market rose 0.4% the same day
· +31.9% · the whole market rose 0.8% the same day
Earlier days
−7.31% market −0.11% Acuvi fell clearly over the week, while the broader Stockholm market was roughly flat. Read →
Acuvi fell clearly over the week, while the broader Stockholm market was roughly flat.
The drop was sharp in the last session and came on heavy trading, well above its usual level.
Acuvi's share price is now at its lowest close of the past year, well below its high from early last year.
Technology stocks on Nasdaq First North Sweden also slipped about 1.1% over the same days, so part of the weakness looks sector-wide.
−0.17% market −0.32% Acuvi was roughly unchanged. Read →
Acuvi was roughly unchanged.
Over the last five trading days it was roughly flat while OMX Stockholm 30 rose slightly.
Its third-quarter report, published the Thursday before, showed sales down but a better underlying margin, which is the profit kept from each sale.
−3.04% market +0.83% Acuvi fell clearly on a semiconductor order. Read →
Acuvi fell clearly on a semiconductor order.
The order is good news, but the stock still moved against a rising market, so the reason is not fully clear.
Over the last five trading days, Acuvi fell slightly while the market rose slightly.
Its recent quarterly report showed lower sales but a better underlying margin, which may still weigh on sentiment.
−1.27% market −0.08% Acuvi moved only slightly lower without a company-news explanation. Read →
Acuvi moved only slightly lower without a company-news explanation.
Over the same session OMX Stockholm 30 was roughly flat, so Acuvi moved while the market held still.
Trading volume was about twice a normal session, pointing to heavier activity than usual.
Its Q3 report, out Thursday last week, showed sales down 18% but better underlying margins, and it likely still shapes sentiment.
Over the last five trading days, Acuvi was roughly unchanged while the market rose slightly.
+4.14% market −0.29% Acuvi rose sharply without a company-news explanation. Read →
Acuvi rose sharply without a company-news explanation.
Acuvi moved against the market: it rose sharply while OMX Stockholm 30 fell slightly.
Over the last five trading days Acuvi fell clearly, while OMX Stockholm 30 rose clearly.
The session's trading was about three times a normal day's volume, so the move drew heavy trading.
The Q3 report, out before that session, showed revenue down and a narrower operating loss, so it may still be in investors' minds.
−4.26% market +3.01% Acuvi fell clearly over the week, moving against a rising market. Read →
Acuvi fell clearly over the week, moving against a rising market.
Its OMX Stockholm 30 index rose clearly over the same days.
The fall came after the company's third-quarter report, published on 20 October, which showed lower sales but better underlying margins and a stronger cash flow.
The report's commentary on a lower-margin inventory correction and a large distribution deal ending likely weighed on sentiment.
−2.58% market +0.41% Acuvi fell clearly, against a rising market. Read →
Acuvi fell clearly, against a rising market.
OMX Stockholm 30 rose slightly that session, while Acuvi moved against it.
The main driver was its Q3 2026 report, which showed lower sales and a sharply weaker operating result.
Sales fell 18% to 47.4 MSEK, mainly from a lost distribution deal and a large 2025 order that did not return.
The company's own adjusted profit figure was better than the reported one, and cash flow improved.
−2.80% market +0.96% Acuvi fell clearly without company news. Read →
Acuvi fell clearly without company news.
Over the last five trading days Acuvi fell sharply, while the market was roughly flat.
The move was big for Acuvi, about twice a normal five-day stretch.
The latest company report, for Q3 2026, came out last week and showed weaker sales and a loss, which may keep weighing on the shares.
The share price is well below its highest close of the past year, near its lowest level.
−2.13% market +1.57% Acuvi fell clearly, without company news. Read →
Acuvi fell clearly, without company news.
Over the last five trading days Acuvi fell clearly, more than the market, which slipped slightly.
The third-quarter report, published last week, showed sales down and a loss, with a large distribution deal ending.
+1.08% market +0.41% Acuvi rose slightly, without clear company news. Read →
Acuvi rose slightly, without clear company news.
Over the last five trading days, Acuvi was roughly unchanged, while the wider Stockholm market fell sharply.
Acuvi's move was an ordinary one for the stock, and its trading was around its usual level.
The main news was the third-quarter report, published earlier this week, which showed sales down and a smaller operating loss.
Next, watch for the company's cash flow and gross margin updates in future reports.
−1.05% market −3.67% Acuvi was roughly unchanged over the last five trading days, while the OMX Stockholm 30 index fell sharply, so Acuvi held up better than the market. Read →
Acuvi was roughly unchanged over the last five trading days, while the OMX Stockholm 30 index fell sharply, so Acuvi held up better than the market.
The move was ordinary in size.
The main news was the third-quarter report, published Tuesday: sales were lower year on year, and the operating loss (EBIT, profit before financial items) widened, though the company said cash flow improved and called part of the loss one-off accounting items.
Management also flagged that a large distribution deal in TPA Motion ended after August, and that stock write-downs are weighing on results.
+1.07% market −2.51% Acuvi rose slightly, against a sharp market fall. Read →
Acuvi rose slightly, against a sharp market fall.
The share moved against the market, which fell clearly over the same day.
The most likely driver is an interview with CEO Nils Sjöholm about the third-quarter results.
He discussed demand, gross margin, cost savings and cash flow.
The trading volume was well below its usual level, so the move was small.
−3.67% market +0.17% Acuvi fell sharply after its quarterly report. Read →
Acuvi fell sharply after its quarterly report.
Acuvi.ST is a Nasdaq Stockholm-listed technology company.
Its shares fell sharply in the last session while the wider market was roughly flat.
The likely reason is the third-quarter report released the day before: sales fell and operating profit (EBIT, earnings before interest and tax) turned negative, with a loss of 7.1 MSEK.
Over the last five trading days, Acuvi was roughly unchanged, while OMX Stockholm 30 eased slightly.
Learn more · Why do stocks go up and down?